I havent seen financial report for last quarter. That being said if sales in first quarter 2021 were $599k and in 2022 $366k did management give any explanation why the drop off? I would think at a minumum the 250 of the trained 400 professional sales persons should be able to generate at least some significate numbers selling Recovery RX to add to the those worldwide sales of Actipatch. I would like to know what contribution the trained sales force is making? If anyone remebers months ago I predicted quarter 2 to be the breakout quarter. I'm not surprised pps is falling to .0005-.0006 range with the latest sales figures giving opportunity to me and others to grab more before Quarter 2 is know. I want to get my average down to .002 by then.
(0)
(0)
BioElectronics Corporation (BIEL) Stock Research Links